Aprovações FDA PMA
Dispositivos com aprovação pré-comercialização acompanhados pelo MedTracker
PMA
2026-02-18
PMA
2026-02-18
Fluorescence in situ hybridization, anaplastic lymphoma kinase, gene rearrangement
Ver detalhes →
PMA
2026-02-18
Fluorescence in situ hybridization, chromosome 17p deletion (TP53)
Ver detalhes →
PMA
2026-02-18
Vagus nerve stimulator for rheumatoid arthritis
Ver detalhes →
PMA
2026-02-17
Daily wear soft contact lens to reduce the progression of myopia
Ver detalhes →
PMA
2026-02-12
replacement Heart-valve
Ver detalhes →
PMA
2026-02-12
heart-valve, non-allograft tissue
Ver detalhes →
PMA
2026-02-12
Device, thermal ablation, endometrial
Ver detalhes →
PMA
2026-02-12
Test, prostate specific antigen, free, (noncomplexed) to distinguish prostate cancer from benign conditions
Ver detalhes →
PMA
2026-02-11
Device, incontinence, mechanical/hydraulic
Ver detalhes →
PMA
2026-02-10
Drug eluting permanent left ventricular (lv) pacemaker electrode
Ver detalhes →
PMA
2026-02-10
Lens, contact, orthokeratology, overnight
Ver detalhes →Nenhum dispositivo correspondente.
Página 40 de 80